The present study suggested that the MMWA intervention could regulate a variety of microbial genera and metabolites related to insomnia, resulting in the reversal of butyrate-mediated abnormalities of the cAMP signaling pathway and GAT-1 expression (Fig 8). The gene discussed is SLC6A1; the disease is insomnia measurement.